• Explore /
  • Poster
  • / Serologic, radiographic, and tissue-based markers associated with major pathologic response after treatment with neoadjuvant immunotherapy in patients with resectable hepatocellular carcinoma.

Serologic, radiographic, and tissue-based markers associated with major pathologic response after treatment with neoadjuvant immunotherapy in patients with resectable hepatocellular carcinoma.

Abstract Poster

Authors

Michael LaPelusa

Michael Brian LaPelusa

The University of Texas MD Anderson Cancer Center, Houston, TX

Michael Brian LaPelusa , Shadi Chamseddine , Lianchun Xiao , Elshad Hasanov , Priya Bhosale , Yehia I. Abugabal , Betul Gok Yavuz , Shalini S. Yadav , Hop Sanderson Tran Cao , Li Xu , Zishuo Ian Hu , Sunyoung S. Lee , Divya Sakamuri , Michael A. Curran , Sonali Jindal , Gabriel Dan Duda , Padmanee Sharma , Aliya Qayyum , Ahmed Omar Kaseb

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 561)

DOI

10.1200/JCO.2024.42.3_suppl.561

Abstract #

561

Poster Bd #

G9

Abstract Disclosures

Similar Posters

First Author: Antonio D'Alessio

First Author: Zhigong Wei

First Author: Antonio D'Alessio

First Author: Robert L. Ferris